-
DiscoveryCounting on combos for complex liver diseases
The best treatment for multifaceted diseases like NASH may be combinations of drugs.
Discovery -
DiscoveryBringing gene therapy into focus
Dr. Botond Roska says we should keep our eyes on gene therapy.
Discovery -
From Our LabsWhat goes wrong with the window to the soul in glaucoma?
Speaking with Ganesh Prasanna, Director of Ophthalmology at NIBR.
From Our Labs -
DiscoveryExperimental gene therapy discovered in-house enters clinical testing
Novartis is taking its investigational gene therapy for a degenerative eye disease into clinical trials.
Discovery -
DiscoveryVisualizing immuno-oncology research
Learn how Novartis researchers are working to outsmart tumors.
Discovery -
People and CultureEnabling 130,000 employees to grow in an organization committed to continuous learning
Our Chief Learning Officer, Simon Brown, talks about our ongoing efforts to build new capabilities by investing in our own people.
People and Culture -
Access to HealthcareNovartis Access impact evaluation: progress update on our work with Boston University
Boston University developed a methodology to evaluate the impact of Novartis Access in Kenya. Peter C. Rockers tells us about the ongoing study.
Access to Healthcare -
From Our LabsHow a 19th-century technology is speeding up drug discovery
Pneumatic tube systems have existed for 150+ years and have transported everything from telegrams to aircraft parts. Now they’re being used in our labs.
From Our Labs -
People and CultureFlexibility at Novartis: Deepti Mittal
Mittal shares how flexible working helped her and her family get through a difficult time.
People and Culture -
People and CultureFlexibility at Novartis: Peter Canavan
Canavan describes how flexible working positively impacts his team.
People and Culture -
DiscoveryWomen in Science: Susanne Schaffert
Susanne Schaffert, President of Advanced Accelerator Applications, describes her career in science.
Discovery -
DiscoveryBringing real change to people
An interview with Thierry Diagana, Head of the Novartis Institute for Tropical Diseases.
Discovery